(NASDAQ: PEPG) Pepgen's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.24%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.2%.
Pepgen's earnings in 2026 is -$71,941,000.On average, 10 Wall Street analysts forecast PEPG's earnings for 2026 to be -$76,898,842, with the lowest PEPG earnings forecast at -$90,272,854, and the highest PEPG earnings forecast at -$70,540,818. On average, 10 Wall Street analysts forecast PEPG's earnings for 2027 to be -$80,029,372, with the lowest PEPG earnings forecast at -$120,816,301, and the highest PEPG earnings forecast at -$53,087,420.
In 2028, PEPG is forecast to generate -$76,718,767 in earnings, with the lowest earnings forecast at -$117,422,585 and the highest earnings forecast at -$59,632,444.